StethoMe focuses on the development of artificial intelligence in the fields of healthcare and telemedicine. It detects abnormal sounds in the respiratory system. Its core product is an electronic stethoscope that coordinates with a smartphone application and specially designed algorithms. The company was founded in 2015 and is based in Poznan, Poland.
StethoMe's Product Videos
StethoMe's Products & Differentiators
Home medical stethoscope that detects abnormal sounds in the respiratory system. With StethoMe, parents can auscultate their child at home, just like an experienced physician and immediately know the result. The system consists of an electronic stethoscope and a StethoMe application that connects to artificial intelligence algorithms in the cloud. Both the stethoscope and AI system are certified Class IIA medical products with CE certification (2274). The system is based on simultaneous detection of abnormal auscultation sounds (wheezes, coarse crackles, fine crackles, and rhonchi) and the measurement of physiological parameters (heart rate, respiratory rate, inhalation to exhalation ratio). If any of the parameters deviate from the normal range, StethoMe will inform the user of this and allows sharing results with doctor.
Research containing StethoMe
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned StethoMe in 1 CB Insights research brief, most recently on Mar 24, 2022.
Expert Collections containing StethoMe
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
StethoMe is included in 3 Expert Collections, including Artificial Intelligence.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Latest StethoMe News
Jul 31, 2020
Movens VC Seeks to Bring €13M into Early-Stage CEE Startups, Invests in StethoMe Movens VC Seeks to Bring €13M into Early-Stage CEE Startups, Invests in StethoMe Movens VC is a newly minted VC fund focusing on early-stage CEE tech companies. The fund is supported by the Polish Development Fund , which has a majority share but keeps out of the investment decisions, mostly to be focused on Seed and Series A deals. Their first investment is StethoMe , a Polish medtech selling an AI-assisted electronic stethoscope. Three more investments to be announced soon. “We are investing!” – Artur Banach , a partner at Movens VC, an early-stage fund based in Warsaw announced triumphally on his LinkedIn profile on July 20th. Indeed, the fund is looking to invest 58 million PLN, or about €13 million, in CEE startups, with a ticket for a given company of up to €450,000. Around 25% of the fund’s dry powder comes from private investors. The rest is sourced from the state-owned Polish Development Fund through its PFR Starter program. Movens VC is primarily focused on: fintech, with additional interest in e-commerce support, logistics, medtech, sport & wellness, industry 4.0, and deeptech. The fund does not exclude other sectors, seeking solutions that utilize AI and machine learning to automate and develop processes in big industries that are ripe for change. The focus is early-stage companies, with the fund offering seed and Series A funding. Michał Olszewski, Partner at Movens VC “Relatively few Polish VC managers have been successful in a tech entrepreneur role. Experience in seeking venture funding outside of Poland is also scarce. Both of these are in our CV and our DNA”. The first breath The fund is run by Michał Olszewski and Artur Banach serving as Partners. Both have an extensive background in tech and VC. Olszewski invested in the payment processor SkyCash as a business angel and later brought it to market leadership as President of the Board. Banach acted as a longtime CEO of Netsprint and later transformed it into the Netsprint Group through a number of M&As, changing a local search engine into a successful martech group. They are joined by Venture Partner Ramon Jimenez , a San Francisco-based fintech advisor, Investment Director Przemysław Jurgiel-Żyła , the former COO of Datarino, and analyst Yaroslav Krempovych , who serves as the Senior Associate. Prior to Movens’ launch, the partners invested in Packhelp , a custom packaging company for e-commerce, and Fenige , a credit card payment processor. The fund’s first official investment, however, is StethoMe , a Poznan-based medtech company that produces a digital stethoscope connected with a dedicated app that uses AI to detect respiratory issues. StethoMe is currently in the commercialization phase, with the product already used in Poland, Spain and France. Source: StethoMe “It’s an example of the kind of tech diamond we are looking for”, said Artur Banach. “The company has global potential and develops machine learning and AI-based technology. The market is very big too, with 50 million families with children in the EU. Telemedicine is growing in importance as a result of the pandemic, too, which drives StethoMe’s growth”, counted Banach. Movens and its co-investors (Manta Ray, TDJ Pitango Ventures, RST Ventures for Earth, and an unnamed Hong Kong-based private investor) raised a combined €2.1 million for StethoMe. “We will soon be announcing three more investments. The sectors will be different, but each company has the chance to be an EU or a global leader”, Banach told ITKeyMedia. Priceless experience The fund also wants to help develop the startup ecosystem through education. The Movens Academy will be offering live webinars for startupers. “Our trademark is that each of us had built tech companies before”, said Artur Banach. “We want to use these experiences to build a platform of various solutions (e.g. HR, digital marketing, international scaling, finance, fundraising) to help companies grow exponentially”. The first series, dedicated to the topic of pricing, starts August 20th. “It is an area often underestimated by founders, which in many cases decides on a startup’s success or failure. Here we can use the expertise of our Partner Maciej Kraus , who has been involved in dozens of pricing projects for tech companies on nearly all continents”, added Banach. “We definitely need more funds like Movens in Poland”, Borys Musielak , Founding Partner at SMOK Ventures , a VC fund primarily investing in gaming and digital products, told us. “Former entrepreneurs and operators running a VC fund while still remembering the founder perspective is crucial, given most of the VC ecosystem in Poland or CEE is still filled with former consultants, PE and finance guys” Artur Banach, Partner at Movens VC “Our trademark is that each of us had built tech companies before. We want to use these experiences to build a platform of various solutions to help companies grow exponentially”. Bridging the gap with public funding The majority investor in Movens VC is the state-owned Polish Development Fund . Its subsidiary PFR Ventures invested 728 million PLN (€165 million) in around 30 VC funds that are to help develop early-stage companies as part of its PFR Starter program. “Due to the profile of the Polish VC market most of the selected funds were actually first time teams”, Robert Sufin , Investment Manager at PFR Ventures, told ITKeyMedia. He added that there are, however, some players with an impressive track record in the fund’s portfolio. With regards to the decision to invest in Movens VC, he admitted: “It’s no mystery that Partners’ experience with Netsprint and SkyCash was of particular importance to us”. Though the Polish government’s support of the startup ecosystem has received criticism in previous years , Movens VC is pleased with the cooperation. “We rate the PFR Starter program, as well as the cooperation, excellent. We are actually quite surprised that investment with public participation can go so smoothly”, Artur Banach told us. “It’s hard to imagine the Polish VC ecosystem catching up to the Western European markets without such state support. A strong VC ecosystem is essential if we want to see a larger amount of Polish tech diamonds succeed”. “When joining our program, a fund pledges to invest in companies at a particular stage of development and agrees to a specified maximum ticket size”, Robert Sufin explained. “We do not, however, interfere in a fund’s assessment of a particular company’s attractiveness. We consciously leave the investment decisions to experienced fund managers. We give the teams full independence”. “PFR Ventures has the right approach to VC investing, as in leaving it to the fund managers to make investment decisions”, confirmed Borys Musielak. “There’s still work to do regarding the bureaucracy and unnecessary restrictions (e.g. in regards to investing in companies formally based outside of Poland or the EU), but not all of those are related to PFR itself, but rather to the general legal system in Poland or EU-related stuff. Still, there is good will and there is flexibility so especially compared to some other investment vehicles Poland has to offer, PFR is doing a great job”. Just fine Despite the pandemic, Polish VC seems to be doing well. “Even in comparison with H1 2019, we’ve had a very good first half of 2020 ”, reported Robert Sufin. “If we exclude DocPlanner’s 350 million PLN megaround in May 2019 (an unusually large transaction), VC investment is 100 million PLN higher than in H1 2019, with 413 million PLN (€94 million) invested.” This is already more than the entirety of 2017 and 2018 combined. “We are expecting to see some big rounds with foreign investors’ participation in the second half of the year. These transactions often reach as high as tens of millions PLN for a single round”, forecast Sufin.
StethoMe Frequently Asked Questions (FAQ)
When was StethoMe founded?
StethoMe was founded in 2015.
Where is StethoMe's headquarters?
StethoMe's headquarters is located at Winogrady 18a, Poznan.
What is StethoMe's latest funding round?
StethoMe's latest funding round is Grant - II.
How much did StethoMe raise?
StethoMe raised a total of $7.9M.
Who are the investors of StethoMe?
Investors of StethoMe include Poland National Research and Development Center, Manta Ray Ventures, TDJ Pitango Ventures, SpeedUp Venture Capital Group, RST Ventures For Earth and 9 more.
Who are StethoMe's competitors?
Competitors of StethoMe include TytoCare, Eko, eKuore, HigoSense, Steth IO and 10 more.
What products does StethoMe offer?
StethoMe's products include StethoMe and 1 more.
Compare StethoMe to Competitors
Eko creates digital health solutions. Its solutions include artificial intelligence (AI) enabled stethoscopes, patient and provider software, and AI-powered analytics that enable doctors, nurses, researchers, and entire health systems to change care for the heart. It serves clients in the healthcare sector. It was founded in 2013 and is based in Oakland, California.
TytoCare provides an online platform for offering primary care at home. It connects people to clinicians to provide virtual home examinations and diagnosis solutions. It was founded in 2011 and is based in New York, New York.
Thinklabs Medical makes the One Digital Stethoscope, featuring patented electromagnetic diaphragm technology. One is a used by clinicians in cardiology, pulmonology, intensive care, telehealth, medical education, and infectious disease, and anyone who demands studio-quality sound.
Sanolla provides artificial intelligence (AI) based primary care diagnostic solutions. It enables early detection and interpretation of asthma, heart failure, and chronic obstructive pulmonary disease (COPD) using infrasound. It was founded in 2016 and is based in Nesher, Israel.
eKuore develops a digital stethoscope. It transmits auscultation to smartphones. It markets its solution to medical professionals. It was founded in 2012 and is based in Valencia, Spain.
Sonavi Labs creates medical devices and software using artificial intelligence (AI). It offers respiratory monitoring and diagnostic support. The company detects and manages respiratory diseases by listening to the sounds of the body and identifying abnormalities. It provides processes for the detection and management of respiratory diseases and infections. Sonavi Labs was founded in 2017 and is based in Baltimore, Maryland.